Latest Breaking News On - Kari alitalo - Page 2 : comparemela.com
University of Helsinki: Finnish coronavirus vaccine developer Rokote Laboratories Finland secures significant funding
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
Finnish company receives funding to develop nasal spray Covid vaccine
yle.fi - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yle.fi Daily Mail and Mail on Sunday newspapers.
Restoring dysfunctional lymphatic networks to allow the body to fight disease
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail
The human body is an incredibly designed machine, and mechanical processes such as those in the lymphatic system play major roles in maintaining healthy tissue and organs.
Donny Hanjaya-Putra is an assistant professor whose work lies at the intersection of engineering and medicine. He studies the lymphatic system the part of the immune system that rids the body of toxins and other unwanted materials. He looks at how to restore dysfunctional lymphatic networks, which are associated with a wide range of diseases, including cancer, cardiovascular disease, diabetes, neurological conditions and metabolic syndromes.
Now Hanjaya-Putra and his team bioengineering doctoral student Laura Alderfer, along with Elizabeth Russo, a 2019 graduate; Adriana Archilla, a student from Syracuse University; and Brian Coe, class of 19 have demonstrated how extracellular matrix stiffness affects lymphatic vessel function.
Finnish nasal vaccine firm scrambles for financing
The professors behind an open source nasal vaccine say that the effort needs tens of millions of euros in funding.
Securing funding for the final phase of the coronavirus nasal vaccine is proving to be difficult, says Kalle Saksela, one of the professors developing the vaccine.
Image: Markku Ulander / Lehtikuva
The researchers behind a nasally-administered coronavirus vaccine under development in Finland say time is running out to get their project off the ground.
They say one problem is the arrival of other vaccines, as clinical trials of vaccines require large numbers of people who have not yet been vaccinated. Meanwhile, because the inoculation is based on open source tech and not patented, enthusiasm among pharmaceutical companies for backing the project has been minimal.